Latest News

Jun 26, 2017

Propanc Biopharma Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer

Pathway Set for PRP to Progress to First-In-Human Studies MELBOURNE, AUSTRALIA -- (Marketwired) -- 06/26/17 -- Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or "the Company"), a…

View All Press Releases